Year Ended December 31, | |||||||||||
2013 | 2012 | 2011 | |||||||||
(in millions) | |||||||||||
Service cost - benefits earned during the period | $ | 1 | $ | — | $ | — | |||||
Interest cost on accumulated benefit obligation | 13 | 16 | 16 | ||||||||
Expected return on plan assets | (7 | ) | (7 | ) | (9 | ) | |||||
Amortization of transition obligation | 6 | 6 | 6 | ||||||||
Amortization of prior service cost | (1 | ) | — | — | |||||||
Amortization of loss | 4 | 3 | 1 | ||||||||
Benefit enhancement | — | 1 | 1 | ||||||||
Net postretirement benefit cost | $ | 16 | $ | 19 | $ | 15 |
Year Ended December 31, | ||||||||
2013 | 2012 | 2011 | ||||||
Discount rate | 3.90 | % | 4.80 | % | 5.20 | % | ||
Expected return on plan assets | 6.00 | % | 6.00 | % | 7.50 | % |
Postretirement Benefit Plan | |||||||
Benefit Payments | Medicare Subsidy Receipts | ||||||
2014 | $ | 21 | $ | (2 | ) | ||
2015 | 22 | (2 | ) | ||||
2016 | 23 | (2 | ) | ||||
2017 | 24 | (3 | ) | ||||
2018 | 25 | (3 | ) | ||||
2019-2023 | 135 | (18 | ) |
Year Ended December 31, | |||||||
2013 | 2012 | ||||||
(in millions) | |||||||
Change in Benefit Obligation | |||||||
Accumulated benefit obligation, beginning of year | $ | 351 | $ | 335 | |||
Service cost | 1 | — | |||||
Interest cost | 13 | 16 | |||||
Benefits paid | (19 | ) | (21 | ) | |||
Participant contributions | 3 | 2 | |||||
Medicare drug reimbursement | 1 | 2 | |||||
Actuarial (gain) loss | (39 | ) | 17 | ||||
Accumulated benefit obligation, end of year | $ | 311 | $ | 351 | |||
Change in Plan Assets | |||||||
Plan assets, beginning of year | $ | 115 | $ | 116 | |||
Benefits paid | (19 | ) | (21 | ) | |||
Employer contributions | 9 | 9 | |||||
Participant contributions | 3 | 2 | |||||
Actual investment return | 6 | 9 | |||||
Plan assets, end of year | $ | 114 | $ | 115 | |||
Amounts Recognized in Balance Sheets | |||||||
Other liabilities-benefit obligations | $ | (197 | ) | $ | (236 | ) | |
Net liability, end of year | $ | (197 | ) | $ | (236 | ) | |
Actuarial Assumptions | |||||||
Discount rate | 4.75 | % | 3.90 | % | |||
Expected long-term return on assets | 6.00 | % | 6.00 | % | |||
Healthcare cost trend rate assumed for the next year - Pre 65 | 7.00 | % | 9.00 | % | |||
Healthcare cost trend rate assumed for the next year - Post 65 | 7.50 | % | 9.00 | % | |||
Prescription drug cost trend rate assumed for the next year | 7.00 | % | 9.00 | % | |||
Rate to which the cost trend rate is assumed to decline (ultimate trend rate) | 5.50 | % | 5.50 | % | |||
Year that the healthcare rate reaches the ultimate trend rate | 2018 | 2017 | |||||
Year that the prescription drug rate reaches the ultimate trend rate | 2018 | 2017 |
U.S. equity | 13-23% |
International equity | 3-13% |
Fixed income | 68-78% |
Cash | 0-2% |